Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Modern Healthcare Is Data‑rich but Insight‑poor
Healthcare now produces unprecedented volumes of real‑world data from EHRs, devices, claims and registries, yet this abundance has not yielded better patient outcomes. The author argues the gap stems from evidence that remains fragmented, retrospective and geared toward compliance rather than decision‑making. Shifting real‑world evidence (RWE) upstream to inform care pathways, resource allocation and policy could turn data into strategic insight. Without unified ownership, the “enterprise evidence gap” limits the impact of analytics and AI on system‑level improvement.
Even Light Drinking Combined with Aging Is Linked to Reduced Brain Blood Flow and Thinner Tissue
A Stanford‑led study published in *Alcohol* found that even low‑level alcohol consumption, when combined with aging, is associated with reduced cerebral blood flow and thinner cortical tissue. Researchers examined 45 healthy adults (22‑70 years) and measured lifetime drinking patterns, brain...
Advancing Drug Discovery with Cell Line Development: Past, Present and Future
Cell line development underpins biologics manufacturing and drug discovery, from historic HeLa and CHO lines to modern CRISPR‑engineered clones. Recent advances in automation, artificial intelligence, and gene editing have accelerated clone selection, improved monoclonality verification, and increased protein yields. Tools...
Amneal to Buy a Biosimilar Company; Samsung Bio Workers Protest
Amneal Pharmaceuticals announced it will acquire biosimilar developer Alvotech for an upfront $375 million, with additional contingent payments tied to regulatory milestones. The deal expands Amneal’s pipeline into high‑margin biologics, adding several approved and late‑stage biosimilar candidates. Concurrently, workers at Samsung...
Improving Connecticut’s Public Health Through Cross-Sector Data-Sharing
Connecticut’s Prevention Data Portal, launched in 2018 by the State Epidemiological Outcomes Workgroup, aggregates local, state, and federal health data to support substance‑use prevention and broader public‑health initiatives. The portal’s success stems from an executive order mandating open data, strategic...
Why Quality Shareback Is the Missing Fuel for the Healthcare Interoperability Engine
Healthcare interoperability has largely solved data access, but the missing piece is high‑quality shareback—returning clinically relevant information after use. Patrick Lane argues that without structured, provenance‑rich, machine‑readable feedback, exchanges remain one‑way and fail to demonstrate outcome improvements. He outlines five...
Health Characteristics of Recreationally Active Female Cannabidiol Users: A Real-World Cross-Sectional Study
A cross‑sectional study of 149 recreationally active women aged 18‑40 examined real‑world cannabidiol (CBD) use. Current users (n=78) reported significantly lower physical activity, shorter sleep duration and poorer quality‑of‑life scores than non‑users, while dietary quality was modestly higher and tobacco...
Risk of Gastrointestinal Intolerance and Complications Associated with Homemade versus Commercial Enteral Nutrition in Critically Ill Patients: A Single-Center Retrospective...
A retrospective cohort of 605 ICU patients compared commercial enteral nutrition (CEN) with hospital‑compounded individualized commercial formulation (ICF). ICF patients experienced markedly lower diarrhea (13.6% vs 41.5%), fewer feeding interruptions, higher mean daily calories (951 kcal vs 893 kcal), and dramatically reduced...
An Evidence Mapping Study Based on Systematic Reviews of Traditional Chinese Medicine for Hyperuricemia
An umbrella review of eleven systematic reviews evaluated Traditional Chinese Medicine (TCM) and integrated TCM‑Western (ITCW) therapies for hyperuricemia. The pooled data suggest that both TCM monotherapy and ITCW reduce serum uric acid levels and improve total effective rates compared...
Adiponectin and Phase Angle in the Assessment of Sarcopenia in Crohn’s Disease: Beyond Muscle Mass
A recent Frontiers in Nutrition study evaluated 150 Crohn’s disease patients and found that both serum adiponectin levels and bioelectrical impedance‑derived phase angle are strong, independent predictors of sarcopenia. Only 8% of the cohort met full sarcopenia criteria, while 71%...
RFKJ Touts “Gold Standard” Science While Ignoring Vaccine Experts
RFKJ: We are bringing back “gold standard science” AOC’s face: Then why are you ignoring all of the science around vaccines? And removing the experts from the ACIP?!
Rural Challenges May Dampen Digital Healthcare's Potential
The Rural Health Transformation Program (RHTP) will funnel $50 billion over five years to all 50 states, with each receiving between $147 million and $281 million in 2026. States must channel the money into digital‑health initiatives such as telehealth hubs, remote patient monitoring,...
Trump Administration Reclassifies Cannabis as Less Dangerous
The U.S. Department of Justice announced that products containing marijuana covered by the FDA or state medical licenses are being moved from Schedule I to Schedule III, putting them on par with codeine‑containing Tylenol. Acting Attorney General Todd Blanche made the change...
The Healthcare Industry Has a Last Mile Problem — It Hasn’t Realized It Yet
The article highlights a “last‑mile” gap in U.S. healthcare, where post‑appointment coordination for seniors often collapses. Discharges, medication adherence, and social‑determinant support lack dedicated resources, leading to readmissions and wasted care. Misaligned fee‑for‑service incentives and unclear accountability keep the problem...
DeepTek, Deepc to Partner on Integrated Radiology AI
DeepTek and deepc have combined their Augmento platform and deepcOS to create a fully integrated AI operating environment for radiology. The solution offers a single operational layer for deploying, orchestrating, and governing multi‑vendor AI across clinical workflows. It targets healthcare...
Epic's Surgical Reply Forces Veeva Into Arbitration Trap
Epic filed their Reply in Veeva Systems v. Epic this week, closing the MTD briefing. The Reply is tight and surgical - Epic quotes Veeva's own opposition back at itself three times in the first paragraph and builds the whole...
Planned Saskatchewan Law Will Raise Fines for Unauthorized Medical Practice
Bill 55, the Medical Profession Amendment Act 2026, will amend Saskatchewan’s Medical Profession Act and Regulated Health Professions Act to expand the College of Physicians and Surgeons of Saskatchewan’s investigative and enforcement powers. The legislation raises maximum fines for unauthorized practice...
Midlife Cardiorespiratory Fitness Adds 1.5 Years to Health Span, Study Finds
Researchers from the Cooper Center Longitudinal Study published today in JACC report that adults with higher cardiorespiratory fitness in midlife develop chronic disease at least 1.5 years later and enjoy longer disease‑free lives. The observational cohort of 24,576 participants links...
Combative, Defensive and Occasionally Contrite, Kennedy Walks a Fine Line
Health Secretary Robert F. Kennedy Jr. endured a marathon of seven congressional hearings on President Trump’s budget, where he alternated between combative defenses and brief apologies. The hearings highlighted his fraught relationship with both the White House and his own base, especially over...
Roche's Fenebrutinib Cuts RMS Relapses to One Every 17 Years in Phase III Trials
Roche announced that its BTK inhibitor fenebrutinib lowered the annualised relapse rate in relapsing multiple sclerosis by 51.1% in FENhance 1 and 58.5% in FENhance 2, translating to roughly one relapse every 17 years. The data, presented at the 2026 AAN meeting,...
Ambience Healthcare Appoints Dr. Michael Han as CMO to Lead Clinical AI Strategy
Ambience Healthcare announced the appointment of Dr. Michael Han, MD, MBA, as its first Chief Medical Officer to lead the company’s clinical AI strategy and platform expansion. Han, formerly Enterprise CMIO at MultiCare Health System and a dual‑board‑certified urologist and...
Zhejiang Xianju Pharma Posts $63M Profit Rise as Revenue Slides 6% in 2025
Zhejiang Xianju Pharmaceutical announced a full‑year profit of RMB449.64 million ($63 million), up 13% from the prior year, even as revenue dropped 6% to RMB3.758 billion ($526 million). The results underscore both resilience in drug‑manufacturing margins and pressure from a slowing domestic market.
New AHA/ACC Guidelines Redefine Heart Disease Prevention
The biggest shift in cardiovascular prevention in years just dropped — and almost no one is talking about it. As a medical school professor, I've watched heart disease stay America's #1 killer for decades. New AHA/ACC guidelines finally move the line. What...
Compounding Risk Alerts
The FDA continues to issue Compounding Risk Alerts to protect patients from unsafe, ineffective, or low‑quality compounded medicines. Recent alerts include potential safety risks from topical finasteride (April 22, 2025), dosing errors in injectable semaglutide (July 26, 2024), and adverse reactions linked to sulfite‑containing...
Kipu Health Acquires Team Recovery Technologies to Unify the Entire Behavioral Health Patient Journey
Kipu Health has acquired Team Recovery Technologies, adding mobile‑first alumni engagement tools to its already extensive behavioral‑health platform. The deal expands Kipu’s reach beyond clinical and billing functions to cover post‑discharge support, aiming to reduce relapse rates. Team Recovery serves...
NovaBridge Names Mark Hagler President & CCO to Boost Pipeline Value
NovaBridge Biosciences announced the appointment of Mark Hagler as President and Chief Commercial Officer. The 25‑year veteran brings experience leading a $1 billion portfolio at Sun Pharmaceuticals and will steer commercial strategy for the company’s two mid‑stage oncology programs, givastomig and...
Australia's NDIS Overhaul Targets 2% Cost Growth, Sparks Employment Concerns
Health Minister Mark Butler announced sweeping changes to the National Disability Insurance Scheme that aim to reduce annual cost growth from 10% to 2% through 2030. The reforms tighten eligibility, tighten provider registration and boost fraud controls, prompting debate over...
Donald Trump Is Giving Psychedelic Medicines a Welcome Boost
President Donald Trump signed an executive order on April 18, 2026, after a text from podcaster Joe Rogan highlighted ibogaine’s potential for opioid addiction. The order directs the FDA to issue priority review vouchers for selected psychedelic drugs and earmarks new...
Episode 61 - GLP-1s, Biosimilars and Pharmacy Spend: Insights From Employers Health's Book of Business
In this episode, Employers Health’s analytics and clinical leaders, Jack Solomon and Hannah Weitzel, discuss how data‑driven strategies are shaping pharmacy spend, focusing on GLP‑1 weight‑loss drugs and autoimmune biologics. They reveal that about 60% of their client base now...
US‑UK Nanotech Partnership Accelerates Low‑Cost HIV Diagnostics
The University of Birmingham and the University of Illinois Urbana‑Champaign have launched a joint effort to develop ultra‑sensitive, low‑cost nanotechnology‑based HIV diagnostics. Backed by UK research council funding and the BRIDGE Signature Initiative, the partnership seeks to bring laboratory‑grade testing...
FDA Approves Novartis' Itvisma Gene Therapy for All Ages with SMA
Novartis announced that the U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec‑brve) for children two years and older, teens and adults with spinal muscular atrophy (SMA). The one‑time intrathecal gene replacement targets the SMN1 mutation, marking the first...
Mile Bluff Medical Center Says Security Incident that Involved Data Encryption Disrupted Phone, Computer Systems
Mile Bluff Medical Center in Mauston, Wisconsin, reported a security incident that encrypted data and disrupted phone and computer systems. Clinical teams immediately shifted to downtime procedures to keep patient care flowing while the hospital activated its security protocols. An...
Hims Secures GLP Deals, Positioning for Retatrutide Boom
This is massively good news for $HIMS members and $HIMS shareholders. $HIMS now selling $LLY GLPs which is Tirzepitide. $HIMS already selling the $NVO GLPs which is Semaglutide. This also means that $HIMS members should have access to Retatrutide...
Endpoints Wins Neal Awards for Trump and Gene Editing Coverage, JPM Event
Endpoints News earned three 2026 Neal Awards, honoring its in‑depth reporting on the pharmaceutical sector’s ties to the Trump administration, a three‑part series on gene‑editing breakthroughs, and its coverage of the JPMorgan health‑care conference. The awards, presented by the American...
New Primary Care Firm Mangrove Health Launches with Investment by Mako
Mangrove Health, a new primary‑care operator, was launched by seasoned healthcare leaders Elena Castañeda and Dr. Emily Maxson. The startup secured an investment from venture firm Mako, signaling confidence in its model. Mangrove aims to deliver integrated, technology‑enabled primary‑care services...
LVOT Accuracy & the Continuity Equation: Why Close Enough Isn't Good Enough
The post warns that a single‑millimeter error in left ventricular outflow tract (LVOT) diameter can dramatically misclassify aortic stenosis (AS) severity, shifting a case from moderate to severe or vice‑versa. LVOT measurement feeds the continuity equation, the cornerstone for calculating...
This Isn’t What I Was Taught
Pediatrician Dr. Gator, once a staunch pro‑vaccine advocate, now emphasizes nuanced informed consent after years of listening to families. He identifies ten factors that reshaped his approach, ranging from observed patient outcomes to legal constraints on public discussion. The full...
Insured Americans Face Significant Hurdles to Mental Health Services
The Mental Health Parity Index reveals that the nation’s four largest commercial insurers provide significantly fewer in‑network mental‑health and substance‑use disorder providers than physical‑health clinicians, with gaps ranging from 24% to 83%. Clinician reimbursement for behavioral health services is 16%‑59%...
New Genetically Engineered CHO Cell Line Boosts Protein Expression and Productivity
Sartorius has unveiled a genetically engineered Chinese hamster ovary (CHO) cell line that delivers up to twice the protein expression titers and three times the productivity of traditional wild‑type CHO hosts. The new line was validated across multiple therapeutic formats—including...
HHS, Industry Leaders Spar over Drug Pricing, TrumpRx and PBMs
At a Politico‑hosted summit, U.S. health officials and pharma leaders clashed over the most‑favored‑nation (MFN) drug‑pricing policy championed by the Trump administration. The MFN proposal would force manufacturers to price drugs in the United States at levels comparable to lower‑cost...
Unnamed Pharma Files Citizen Petition Targeting FDA’s Trove of Rejection Letters
An unnamed pharmaceutical firm has lodged a citizen petition urging the FDA to halt its new practice of automatically publishing complete response letters (CRLs). The petition seeks a 10‑day notice period for sponsors to contest disclosure and a clear redaction...
These 80-Year-Olds Have the Memory of 50-Year-Olds. Scientists Now Know Why
Northwestern Medicine’s 25‑year SuperAging program has identified a cohort of 80‑plus adults whose memory performance matches that of people in their 50s. Researchers found that these “SuperAgers” exhibit unusually thick cortical regions and a higher density of von Economo neurons, which...
Dr George Fareed and Dr Paul Oosterhuis on the Breakthroughs with Turbo-Cancer Treatment
In this episode, Dr. George Fareed and Dr. Paul Oosterhuis discuss their "Turbo‑Cancer" protocol, a repurposed‑drug regimen originally developed for COVID‑19 that they claim has treated between 10,000 and 20,000 patients. They outline the core components—hydroxychloroquine, zinc, doxycycline or azithromycin,...
AAN 2026: J&J, Kyverna, Capricor and Praxis Showcase Practice-Changing Data
At the 2026 American Academy of Neurology meeting, Johnson & Johnson reported two‑year Phase 3 data showing its FcRn blocker Imaavy sustained symptom improvement and allowed most patients to cut corticosteroid use. Kyverna Therapeutics presented Phase 2 results for its CAR‑T therapy...
DemeRx Reports the US FDA IND Application Acceptance to Advance DMX-1001 for Alcohol Use Disorder
DemeRx announced that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for DMX-1001, an oral formulation of noribogaine, to treat alcohol use disorder (AUD). The company recently completed a multiple‑ascending‑dose (MAD) trial in healthy...
Senior Lucy Letby Hospital Boss Arrested
A senior executive at the Countess of Chester Hospital was arrested on suspicion of perverting the course of justice, part of Cheshire Police's Operation Duet. The operation investigates both corporate manslaughter and gross negligence manslaughter linked to the 2023 convictions of...
AI Chip Giant Outvalues Entire Global Pharma Industry
NVIDIA is now worth more than the entire Big Pharma combined on the stock market. I shared this image from Reza Zahiri, PhD, MBA, 6 months ago. NVIDIA’s market cap now hit $4.9 trillion ($0.3 trillion more than then), which...
Lab‑grown Sperm Creates Embryos, Easing Dystopian Fears
Lab-grown sperm used to create embryos for the first time. Good news if you were worried about the Handmaid's Tale trajectory. https://t.co/q6gItYuGoJ
Trump Appoints Former Tobacco Exec to Top CDC Role
The Trump administration has crammed an astonishing number of political appointees into the highest echelons of #CDC, most with few or no medical or public health credentials. One of the latest is surprising: A former Big Tobacco exec. https://t.co/8jA8qfqMv6
Half‑million UK Medical Records Listed for Sale After Breach
Medical data of 500,000 people in UK put up for sale after data breach - https://t.co/zBa4Kbu9u3 via @FT